SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-010006
Filing Date
2022-01-14
Accepted
2022-01-14 17:11:05
Documents
13
Period of Report
2021-11-19
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d280311d8ka.htm   iXBRL 8-K/A 27990
2 EX-16.1 d280311dex161.htm EX-16.1 1937
  Complete submission text file 0001193125-22-010006.txt   160050

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bttx-20211119.xsd EX-101.SCH 2915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bttx-20211119_lab.xml EX-101.LAB 18835
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bttx-20211119_pre.xml EX-101.PRE 11860
7 EXTRACTED XBRL INSTANCE DOCUMENT d280311d8ka_htm.xml XML 4363
Mailing Address 311 WEST 43RD STREET, 12TH FLOOR NEW YORK NY 10036
Business Address 311 WEST 43RD STREET, 12TH FLOOR NEW YORK NY 10036 646-493-6558
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1028
Type: 8-K/A | Act: 34 | File No.: 001-39864 | Film No.: 22532632
SIC: 8000 Services-Health Services
Office of Life Sciences